The ‘Real Housewives of Beverly Hills’ alum shared the health reminder amid a frank look at the struggles of ongoing immunotherapy ...

Instead of attacking cancer directly, these treatments, including nivolumab (Opdivo) and pembrolizumab (Keytruda), keep your immune system active to help it recognize and destroy cancer cells more ...

DENVER & SAN DIEGO--(BUSINESS WIRE)--TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients ...

Dipika Kakar shared that she had earlier reduced her tea intake to once a week, but because of immunotherapy, she can't even ...

A single infusion of chimeric antigen receptor T-cell (CAR-T) therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small ...

Subcutaneous (SC) formulations of monoclonal antibodies are rapidly transforming the delivery of cancer immunotherapy. Designed to replace or complement intravenous (IV) administration, SC delivery ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

A person receives subcutaneous immunotherapy as an injection under the skin. This treatment method has shown similar effectiveness to intravenous (IV) infusions that healthcare professionals often use ...

This newer mode of administration for immunotherapy comes with benefits and risks. It is important for a person to work with a doctor when making treatment decisions for upper gastrointestinal (GI) ...

Demand for immunotherapies is climbing, with the global market on track to go from approximately $95 billion at a CAGR of 13.2 percent to an estimated $320 billion by 2033, according to Uniprism ...